NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
Back to search
Official data from USPTO
ONCODETECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/13/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
03/18/2025
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/24/2025
First use in commerce
04/24/2025
Drawing code
5
Owner type
03
Owner location
Madison, WI, US
Examiner
HAYASH, SUSAN C
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of stylized mark ONCODETECT.
Holders and representatives
Holders
Genomic Health, Inc.
Representatives
Sana Hakim K&L Gates LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing laboratory research services in the field of genetic testing for the detection and screening of cancerdevelopment of assays for detection of tumor-specific biomarkers in tumor tissue and blood; medical and scientific laboratory services in the field of genetic testing for the detection and screening of cancerdevelopment of assays for detection of tumor-specific biomarkers in tumor tissue and blood
Class 44
Medical testing servicesgenetic testing for the detection and screening of canceruse of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and bloodtesting for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness; providing medical testing services for the detection and screening of cancer and information for treatment purposes in the field of genetic research and disease classificationuse of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and bloodtesting for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2025
GNRT
NON-FINAL ACTION E-MAILED
08/20/2025
CNRT
NON-FINAL ACTION WRITTEN
08/20/2025
IUAA
USE AMENDMENT ACCEPTED
08/20/2025
DOCK
ASSIGNED TO EXAMINER
08/18/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/09/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/29/2025
IUAF
USE AMENDMENT FILED
05/29/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/29/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/18/2025
NWAP
NEW APPLICATION ENTERED
03/18/2025
Continuous trademark protection
Get notified about every new filing that threatens ONCODETECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.